Mylan CEO Heather Bresch says keeping drug price hikes below 10% isn’t the answer By: MarketWatch January 11, 2017 at 14:22 PM EST Bresch said the drug pricing model in the U.S. has to change, but offers few suggestions as to how. Read More >> Related Stocks: Allergan Plc Johnson & Johnson Mylan